Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03455946 · ClinicalTrials.gov registry record · NA
Testing the Feasibility of the DASH Cloud Intervention Using Amazon Alexa
A NA study of Behavior, Health and Diet Modification, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT03455946: Completed NA study of Behavior, Health and Diet Modification, sponsored by Duke University.
NCT03455946 is a NA study of Behavior, Health and Diet Modification that has completed, run by Duke University. The registered enrollment target is 26 participants, below the 15,790-participant average among 20 other Behavior, Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03455946, a NA study of Behavior, Health and Diet Modification, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The DASH diet is a proven behavioral strategy to reduce blood pressure, however, national adherence rates are poor. Using digital health tools may help to improve adoption of the DASH diet. Digital health approaches capitalize on the ubiquitous utilization of mobile technologies and have broad dissemination potential. There have been few efforts to test a DASH intervention via digital, and none using voice-activated technologies (e.g, Amazon Alexa). This proposal will enroll up to 20 participants to leverage a commercial diet tracking application, an existing intervention technology platform and the Amazon Echo Dot to test the feasibility of using DASH Cloud, a digital health intervention, with the Amazon Alexa personal assistant.
Primary Outcome
Utilization of intervention components at 3 months as indicated by the system usability scale
Conditions Studied
Interventions
- BEHAVIORAL DASH cloud with Alexa
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2018-12-17 |
| Phase | NA |
What the finished NCT03455946 record still lists
NCT03455946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 15,790-participant average among 20 other Behavior, Health trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Behavior, Health appearing as the primary indexed condition, and to 1 intervention - of which DASH cloud with Alexa is the first listed.
NCT03455946 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03455946 about?
NCT03455946 is a clinical study titled "Testing the Feasibility of the DASH Cloud Intervention Using Amazon Alexa". The DASH diet is a proven behavioral strategy to reduce blood pressure, however, national adherence rates are poor. Using digital health tools may help to improve adoption of the DASH diet. Digital health approaches capitalize on the ubiquitous utilization of mobile technologies and have broad disse...
What is the current status of trial NCT03455946?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2018-07-23. Estimated completion is 2018-12-17.
What conditions does trial NCT03455946 study?
This clinical trial studies the following conditions: Behavior, Health, Diet Modification.
What interventions are being tested in trial NCT03455946?
The interventions under investigation include: DASH cloud with Alexa (BEHAVIORAL).
Who is sponsoring clinical trial NCT03455946?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03455946 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavior, Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03455946's enrollment target sits among peer trials
26 18th of 20 higher than 3 of 20 other Behavior, Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Behavior, Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Fit With Us Study
RECRUITING · NA
-
Parent-Child Memory Study: Improving Future Thinking Among Mothers
RECRUITING · NA
-
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
RECRUITING · NA
-
Game-based Pediatric Diabetes Education
RECRUITING · NA
-
Personalized Health Self-Management Training for Colorectal Cancer Survivors
RECRUITING · NA
-
Improving Congenital Heart Disease Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI